Avidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassays - Wikidata - wikimedia - TriplyDB

Avidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassays

Avidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassays

http://www.wikidata.org/entity/Q35140064

about

Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014 Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies.Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes Development and application of a high-throughput microneutralization assay: lack of xenotropic murine leukemia virus-related virus and/or murine leukemia virus detection in blood donors.Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs.Modification of AxSYM Human Immunodeficiency Virus Assay to Identify Recent Human Immunodeficiency Virus Infections in Korean Human Immunodeficiency Virus-Positive Individuals Moving towards a reliable HIV incidence test - current status, resources available, future directions and challenges ahead.Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms.MSM in Bogotá are living with HIV for extended periods without diagnosis or treatment.Viral load criteria and threshold optimization to improve HIV incidence assay characteristics Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.Identifying recently acquired HIV infections among newly diagnosed men who have sex with men attending STI clinics in The Netherlands.Assays for estimating HIV incidence: updated global market assessment and estimated economic value.

P2860

Q33706522-980F620D-3C5F-4E8A-A437-3778BD358BAC Q33892444-7B12DC4C-5E38-4728-A877-52CA3E1F8164 Q33916829-F76C4776-F4BA-4E84-835C-9762CFFAFF7D Q34058732-F77FBB16-FFCE-4187-A622-242B780DFA4C Q34214893-3CD69632-8A75-4E7A-89CB-EDBB44BDF415 Q35119643-3384FD29-5C82-46C1-B9C5-5E6E34CDF11A Q35821936-2ADF2B70-7239-40C8-8741-F6AC4C7ADF3F Q35824686-9A6D964E-B54F-4928-BA06-AAB86ACF8C55 Q36000117-C494B7A2-6515-4E54-8B67-08141A99BBEC Q38779402-3EF43509-8A39-4333-A776-B5ADF4FE8293 Q40044059-D9EB3C51-3CA5-4279-B204-55809D8963B0 Q40441518-1461C44A-69F0-4450-8B0A-6780DEB972C9 Q40601041-849A9E9B-AD9F-4B0D-8897-81FED04E9F76 Q40751062-1DDEC81A-9836-4EF6-AF4E-01209625C0E3 Q42230804-91EB3942-9777-4F82-99A7-6AF44D26AA2D Q48253997-F20C071B-F408-49DF-9C2E-1256B159A13D

P2860

Avidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassays

http://www.wikidata.org/entity/Q35140064

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Avidity Index for anti-HIV ant ...... eration automated immunoassays

@ast

Avidity Index for anti-HIV ant ...... eration automated immunoassays

@en

type

label

Avidity Index for anti-HIV ant ...... eration automated immunoassays

@ast

Avidity Index for anti-HIV ant ...... eration automated immunoassays

@en

prefLabel

Avidity Index for anti-HIV ant ...... eration automated immunoassays

@ast

Avidity Index for anti-HIV ant ...... eration automated immunoassays

@en

P1433

Q35140064-A56C8D87-A0C6-4C69-83A7-5A2AFA899033

P1476

Q35140064-70E48607-4850-4EA2-A233-FC1AD3F22AFC

P2093

Q35140064-1BC180C6-A0A7-4AF0-B666-88C95E15B5F5

Q35140064-57680DA1-C499-4D67-A462-D90C56167822

Q35140064-7FAEC12D-2EF1-472D-8021-32C48289E3C4

Q35140064-96E96612-8A7C-43F1-8173-F9C637A18712

Q35140064-A81B318E-44B5-4399-8B73-9D8656F202E9

Q35140064-BD227BF5-FE31-4035-AD31-27FD8AAB5ABC

Q35140064-C23C9276-6114-4DD9-A229-6EC4AFDB0227

Q35140064-C4F18E3C-5DDC-404B-B2E0-D43B9282DBA5

Q35140064-CBB377E9-A590-40D4-BE4D-EFEDF07D11B3

Q35140064-F798B2B6-9932-4BA1-A451-268EB1B255CB

P2860

Q35140064-14EB12AC-8EA9-46DE-BA7A-7ABD0C4B71A1

Q35140064-1589ACA3-D372-4577-9EAA-28C0F7D98D53

Q35140064-3A5D808F-F6C9-43DF-99F3-15BC59232C58

Q35140064-3F0E93C7-738C-4767-9DC0-BAC7ECF007F0

Q35140064-49E965E3-EF01-4B37-B15C-13CF068A29B9

Q35140064-88E459DC-945E-474F-9EF9-BB49C6363565

Q35140064-92115E57-9888-480A-BA99-D8DEC94DFFEF

Q35140064-9E1C228B-FD55-44C6-9B8F-F9F3C73AC285

Q35140064-C97F1466-13EE-409D-846E-A72E1FA8D84B

Q35140064-EC19E934-22E6-457D-B88F-BDC6714AE196

P304

Q35140064-9672B221-FBB1-4EC8-9D33-4D8670733962

P31

Q35140064-D0F8CC55-62E2-4B5E-880C-7E3D7956F192

P356

Q35140064-19A89848-391E-41C1-A8B5-4190A6BE73DF

P407

Q35140064-FADB4CAE-618D-4C84-8AAE-493B66A79573

P433

Q35140064-9092EAE1-F629-491A-A3B2-E2669DF6C96C

P478

Q35140064-3F959CFF-570A-4474-8B0F-65EBF3C8D7FF

P577

Q35140064-1A122707-1D9C-41B3-BF22-B3C2BE9FF9C1

P5875

Q35140064-0816C108-76E7-427B-BDE7-DE28F24D279E

P698

Q35140064-8F3267F3-4DB4-4080-9307-40EB00581EEB

P932

Q35140064-F7F9466E-8203-4A75-9880-E7F3900FE399

P356

P1433

Journal of Clinical Microbiology

P1476

Avidity Index for anti-HIV ant ...... eration automated immunoassays

@en

P2093

Anna Rodella

http://www.w3.org/2001/XMLSchema#string

Barbara Suligoi

http://www.w3.org/2001/XMLSchema#string

Claudio Galli

http://www.w3.org/2001/XMLSchema#string

Laura Camoni

http://www.w3.org/2001/XMLSchema#string

Luigina Terlenghi

http://www.w3.org/2001/XMLSchema#string

Maria Cristina Salfa

http://www.w3.org/2001/XMLSchema#string

Mariangela Raimondo

http://www.w3.org/2001/XMLSchema#string

Nino Manca

http://www.w3.org/2001/XMLSchema#string

Salvatore Casari

http://www.w3.org/2001/XMLSchema#string

Vincenza Regine

http://www.w3.org/2001/XMLSchema#string

P2860

Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays

Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections.

Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots.

Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method

Assays for the detection of recent infections with human immunodeficiency virus type 1.

Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review.

Detection of recent HIV infections in African individuals infected by HIV-1 non-B subtypes using HIV antibody avidity.

Suggested strategies for the laboratory diagnosis of HIV infection in Italy.

Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting.

Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence.

P304

2610-2613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.02115-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51099289

http://www.w3.org/2001/XMLSchema#string

P698

21543577

http://www.w3.org/2001/XMLSchema#string

P932

3147844

http://www.w3.org/2001/XMLSchema#string